The aim of this study is to examine the associations between serum concentrations of IGF-I, IGF-II and IGFBP-3 and subsequent breast cancer risk in a case–control study nested within a cohort of women on the island of Guernsey. Here, IGFBP3 is linked to breast carcinoma.